Tekturna (Noden Pharma USA, Inc.)


Welcome to the PulseAid listing for the Tekturna drug offered from Noden Pharma USA, Inc.. This Renin Inhibitor [EPC],Renin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Noden Pharma USA, Inc.
NON-PROPRIETARY NAME: aliskiren hemifumarate
SUBSTANCE NAME: ALISKIREN HEMIFUMARATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Renin Inhibitor [EPC],Renin Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2007-03-05
END MARKETING DATE: 0000-00-00


Tekturna HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTekturna from Noden Pharma USA, Inc.
LABELER NAME: Noden Pharma USA, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 150(mg/1)
START MARKETING DATE: 2007-03-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70839-150_c3d6f2d0-6154-49c1-8758-a87cbf88f59d
PRODUCT NDC: 70839-150
APPLICATION NUMBER: NDA021985

Other ALISKIREN HEMIFUMARATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalTekturna
Noden Pharma USA, Inc.Tekturna
Novartis Pharmaceuticals CorporationTekturna
Physicians Total Care, Inc.Tekturna